Short description
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Description
Arcturus Therapeutics is a late-stage clinical mRNA medicine company that focuses on developing novel RNA therapeutics for the treatment of various rare diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents, USPTO granted) that allow the targeting of any gene in the human genome.
It was founded in 2013 and is headquartered in San Diego, California.
Last funding
Nopepepe
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2013
Exited on
November 16, 2017
Went public on
November 16, 2017
Stock symbol
ARCT
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
No Way, Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Joseph Payne, Pad (Padmanabh) Chivukula